Unknown

Dataset Information

0

Targeting Gα13-integrin interaction ameliorates systemic inflammation.

ABSTRACT: Systemic inflammation as manifested in sepsis is an excessive, life-threatening inflammatory response to severe bacterial or viral infection or extensive injury. It is also a thrombo-inflammatory condition associated with vascular leakage/hemorrhage and thrombosis that is not effectively treated by current anti-inflammatory or anti-thrombotic drugs. Here, we show that MB2mP6 peptide nanoparticles, targeting the Gα13-mediated integrin "outside-in" signaling in leukocytes and platelets, inhibited both inflammation and thrombosis without causing hemorrhage/vascular leakage. MB2mP6 improved mouse survival when infused immediately or hours after onset of severe sepsis. Furthermore, platelet Gα13 knockout inhibited septic thrombosis whereas leukocyte Gα13 knockout diminished septic inflammation, each moderately improving survival. Dual platelet/leukocyte Gα13 knockout inhibited septic thrombosis and inflammation, further improving survival similar to MB2mP6. These results demonstrate that inflammation and thrombosis independently contribute to poor outcomes and exacerbate each other in systemic inflammation, and reveal a concept of dual anti-inflammatory/anti-thrombotic therapy without exacerbating vascular leakage.

SUBMITTER: Cheng N 

PROVIDER: S-EPMC8159967 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Targeting Gα<sub>13</sub>-integrin interaction ameliorates systemic inflammation.

Cheng Ni N   Zhang Yaping Y   Delaney M Keegan MK   Wang Can C   Bai Yanyan Y   Skidgel Randal A RA   Du Xiaoping X  

Nature communications 20210527 1

Systemic inflammation as manifested in sepsis is an excessive, life-threatening inflammatory response to severe bacterial or viral infection or extensive injury. It is also a thrombo-inflammatory condition associated with vascular leakage/hemorrhage and thrombosis that is not effectively treated by current anti-inflammatory or anti-thrombotic drugs. Here, we show that MB2mP6 peptide nanoparticles, targeting the Gα<sub>13</sub>-mediated integrin "outside-in" signaling in leukocytes and platelets,  ...[more]

Similar Datasets

Unknown Integrin β<sub>3</sub> directly inhibits the Gα<sub>13</sub>-p115RhoGEF interaction to regulate G protein signaling and platelet exocytosis.
| S-EPMC10432399 | biostudies-literature
Unknown Gα<sub>13</sub> Mediates Transendothelial Migration of Neutrophils by Promoting Integrin-Dependent Motility without Affecting Directionality.
| S-EPMC9117564 | biostudies-literature
Unknown CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα<sub>12/13</sub>.
| S-EPMC5496032 | biostudies-literature
Unknown Amphetamines signal through intracellular TAAR1 receptors coupled to Gα<sub>13</sub> and Gα<sub>S</sub> in discrete subcellular domains.
| S-EPMC7038576 | biostudies-literature
Unknown The PAR2 inhibitor I-287 selectively targets Gα<sub>q</sub> and Gα<sub>12/13</sub> signaling and has anti-inflammatory effects.
| S-EPMC7695697 | biostudies-literature
Unknown Naturally occurring hotspot cancer mutations in Gα<sub>13</sub> promote oncogenic signaling.
| S-EPMC7864081 | biostudies-literature
Unknown Receptor selectivity between the G proteins Gα<sub>12</sub> and Gα<sub>13</sub> is defined by a single leucine-to-isoleucine variation.
| S-EPMC6436656 | biostudies-literature
Unknown Regulation of neurite morphogenesis by interaction between R7 regulator of G protein signaling complexes and G protein subunit Gα<sub>13</sub>.
| S-EPMC5473243 | biostudies-literature
Unknown Targeting Oncogenic Gα<sub>q/11</sub> in Uveal Melanoma.
| S-EPMC8699590 | biostudies-literature
Unknown Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gα<sub>q</sub> and Gα<sub>13</sub> proteins.
| S-EPMC6333895 | biostudies-literature